肺动脉高血压中的肠道微生物组 - - 一个新兴的前沿领域
Sasha Z Prisco1, Suellen D Oliveira2, E Kenneth Weir1
1Cardiovascular Division, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.
肠道疾病,肠道细菌的不平衡,与肺动脉高血压 (PAH) 的进展有关. 改变肠道微生物组可能为PAH患者提供新的治疗策略.
科学领域:
- 胃肠道学和免疫学
- 心脏病学 心脏病学
- 微生物学 微生物学
背景情况:
- 肺动脉高血压 (PAH) 是一种严重的疾病,导致右心室衰竭.
- 目前用于PAH的治疗方法缺乏足够的疗效,这突显了需要新的辅助疗法.
- 肠道微生物组在调节免疫反应中的作用为PAH提供了潜在的治疗途径.
研究的目的:
- 审查将肠道失调与PAH联系在一起的证据.
- 探索针对肠道微生物群作为PAH治疗策略的潜力.
- 讨论将微生物组研究转化为PAH临床应用的挑战.
主要方法:
- 对PAH的肠道微生物组变化的临床前和临床研究的综述.
- 分析肠道失生症可能影响PAH病变的机制.
- 检查微生物组调制策略及其临床适用性.
主要成果:
- 新出现的证据表明PAH患者的肠道显著失调.
- 肠道微生物组的变化可能会通过影响系统免疫力来启动或加剧PAH.
- 感染也与PAH的发展和进展有关.
结论:
- 肠道功能失调是PAH病原和进展的一个重要因素.
- 准肠道微生物组为PAH提供了一个有前途的辅助治疗方法.
- 需要进一步的研究来阐明机制并克服临床翻译的挑战.
更多相关视频
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
11:23Purifying the Impure: Sequencing Metagenomes and Metatranscriptomes from Complex Animal-associated Samples
Published on: December 22, 2014
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Microorganisms in Medicine and Therapeutics
Chronic Obstructive Pulmonary Disease-I: Introduction
Gene Regulation in Microbial Communities: Quorum Sensing
